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INTRODUCTION
Endovascular embolization using liquid embolic agents 
such as N-butyl cyanoacrylate (NBCA; Histoacryl, B Braun, 
Tuttlingen, Germany) or Onyx (Medtronic, Irvine, CA, 
USA) is a widely accepted treatment option for spinal and 
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cranial vascular diseases (1-3). The penetration or delivery 
of a sufficient amount of liquid embolic agent into the 
target shunt or nidus is key to successful embolization 
in abnormal neurovascular shunt diseases (1-4). For this 
purpose, a microcatheter wedge technique for NBCA delivery 
and proximal plug formation or dual-lumen balloon catheter 
Korean J Radiol 2019;20(8):1285-1292
eISSN 2005-8330
https://doi.org/10.3348/kjr.2019.0127
Original Article | Neurointervention
1286
Park et al.
https://doi.org/10.3348/kjr.2019.0127 kjronline.org
for Onyx delivery have been used (5-7). In the majority 
of cases, these techniques allow controlled delivery of a 
sufficient amount of the embolic agent into the target shunt 
or nidus and prevent unintentional reflux or premature 
occlusion of the major draining veins (5, 7-9). However, 
small and tortuous feeding arteries may preclude navigation 
of a microcatheter close enough to the target lesion or 
wedging of the microcatheter tip, which are essential for 
safe and effective embolization with a liquid agent. The 
coil-protected technique may be useful in cases of cranial 
and spinal vascular diseases where navigation or wedging of 
a microcatheter close to the target lesions is difficult.
Therefore, this study aimed to evaluate the safety and 
effectiveness of the coil-protected liquid embolization 
technique for the treatment of various neurovascular shunt 
diseases. 
MATERIALS AND METHODS
Data for patients who underwent coil-protected liquid 
embolization for cranial and spinal shunts or malformations 
were retrieved from a prospectively maintained 
neurointerventional database of a tertiary referral academic 
hospital. The coil-protected technique was applied as 
a rescue method in all cases wherein a microcatheter 
could not to be navigated distal enough to wedge the 
target feeding artery because of severe tortuosity of the 
target feeding artery. For these cases, the coil-protected 
technique was expected to promote penetration or delivery 
of a sufficient amount of liquid embolic agent into the 
target shunt or nidus by blocking unintentional reflux 
during injection of liquid embolic agent and retrieval of 
the microcatheter used for embolization. The procedural 
technique is illustrated in Figure 1.
Patient demographic data, lesion characteristics, and 
procedural and clinical outcomes of the coil-protected 
technique were retrospectively analyzed by reviewing the 
electronic medical records, procedural digital subtraction 
angiography data, and the prospectively maintained 
neurointerventional database, in which procedural 
Proximal coil protected embolization in torturous feeder artery
Microcatheter
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Venous outflow
Liquid embolic
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Reflux of liquid embolic agent at non-wedging of microcatheter tip in torturous feeder artery
Microcatheter
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High lesion pressure
Venous outflow
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B
Fig. 1. Illustration of coil-protected technique. 
A. During liquid embolization with non-wedging microcatheter tip due to arterial tortuosity, penetration of liquid embolic agent is impossible and 
early reflux occurs. B. Coil-protected technique makes it possible to deliver liquid embolic agent to target shunt without reflux proximal to coil mass.
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details and complications had been recorded. Clinical 
outcomes were evaluated on the basis of clinical and 
radiologic examinations at the most recent outpatient 
visit or readmission. If the most recent outpatient visit or 
readmission was more than three months before the time 
of data collection, patients’ outcomes were determined 
by telephone interviews performed by a trained clinical 
research nurse. The Institutional Review Board approved 
this study and waived the requirement for informed patient 
consent because of the retrospective study design.
Of the 153 patients who underwent endovascular 
treatment for neurovascular arteriovenous fistula (AVF) or 
arteriovenous malformation (AVM) between December 2014 
and December 2018, 22 (14.3%) were treated with the coil-
protected liquid embolization technique. Baseline patient 
characteristics are summarized in Table 1. The patient 
population consisted of 12 men and 10 women (mean age, 
median 52 years; range, 3–70 years). The patients had eight 
spinal AVFs, seven cerebral AVFs, six cerebral AVMs, and one 
mandibular AVM. One patient who was suspected to have 
Maffuci’s syndrome had multiple cranial AVFs (Fig. 2) and 
hemangiomas in the liver. The coil-protected technique was 
applied to facilitate delivery of a sufficient amount of the 
liquid embolic agent into the target shunt or target point 
(suspected rupture point or intranidal aneurysm) of the AVM 
nidus or was used to prevent unintentional reflux of the 
embolic agent to a functional arterial branching point of 
the feeding artery.
Endovascular Procedure
All planned Onyx embolizations for AVM cases were 
performed under general anesthesia, while planned NBCA 
embolizations for AVF were performed under either general 
or local anesthesia at the operator’s discretion. A 6-Fr 
shuttle sheath or 6-Fr Envoy guiding catheter (Cerenovus, 
Fremont, CA, USA) was placed in the relevant parent artery. 
If needed, a double-guide catheter system (6-Fr Envoy or 
5-Fr Sofia catheter [Microvention, Tustin, CL, USA] within 
a 6-Fr shuttle sheath [Cook, Bloomington, CL, USA]) was 
used. In addition, bi-femoral access was preferred in cases 
where multiple feeders arose from different parent arteries. 
Generally, the coil-protected technique was not used unless 
a microcatheter wedge or dual-lumen balloon catheter 
advancement to a target arterial point failed. When using 
the coil-protected technique, the first microcatheter 
(Marathon, Covidien, Plymouth, MN, USA) was navigated 
as far as possible to the most distal point of the feeding 
artery, after which the second microcatheter (Prowler-10, 
Codman, Fremont, CA, USA or Excelsior-10, Stryker, 
Fremont, CA, USA) was navigated just proximal to the first 
microcatheter by using a compatible microwire. Using the 
second microcatheter, the feeding artery was occluded by 
placement of detachable coils at a point proximal to the 
first microcatheter tip (Fig. 2). Blockage of arterial inflow 
was confirmed through a guide catheter angiogram. The 
absence of reflux proximal to the feeding artery segment 
where the coil mass was placed was also confirmed with 
an angiogram through the first microcatheter (Fig. 3). 
The final coil was left in place without being detached to 
ensure the stability of the coil mass at the point of rapid 
retrieval of the microcatheter used for liquid embolization. 
Embolization was performed using a low-concentration 
NBCA-lipiodol mixture (NBCA, 10–20%), Onyx-18, or both 
depending on the geography of the feeders and the target 
lesions (Fig. 4). After embolization, the first microcatheter 
was retrieved. Finally, the final coil was detached and 
the second microcatheter was retrieved. The procedure 
was considered technically successful if the target lesion 
was sufficiently filled with liquid embolic agent without 
unintentional reflux. Angiographic results were evaluated 
independently by an interventional neuroradiologist who did 
not treat the patients and classified into complete, near-
complete, and partial occlusion. Complete occlusion was 
defined as no visualization of the shunted cortical vein or 
AVM nidus in the delayed venous phase on the completion 
angiogram. Near-complete occlusion was defined as delayed 
Table 1. Baseline Clinical and Angiographic Characteristics
Variables Values
Age (years), median (range) 52 (3–70)
Sex (male:female), n 12:10
Clinical presentations, n (%)
Non-hemorrhagic neurological deficits 9 (86.4)
Intracranial hemorrhage 6 (27.3)
Headache 3 (13.6)
Seizure 2 (9.1)
Headache and exophthalmos 1 (4.5)
Hypovolemic shock due to massive oral bleeding 1 (4.5)
Locations, n (%)
Intracranial 13 (59.1)
Spine 8 (36.4)
Mandible 1 (4.5)
Lesion types, n (%)
Arteriovenous fistula 15 (68.2)
Arteriovenous malformation 7 (31.8)
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visualization of the shunted vein or AVM nidus in the venous 
phase, with marked stasis of contrast agent (longer than 2 
seconds). Partial occlusion was defined as visualization of 
the shunted vein or AVM nidus in the arterial phase on the 
completion angiogram, with contrast material stasis shorter 
than 2 seconds (7).
Statistical Analysis
Since this study only included the results of the coil-
protected technique for liquid embolization without any 
comparisons with other techniques, only descriptive 
statistics are presented. All data are presented as the mean 
and range for continuous variables and as a number and 
percentage for categorical variables. 
RESULTS
Detailed information regarding liquid embolic agents and 
treatment outcomes are presented in Table 2. A total of 36 
feeding arteries in 22 patients were embolized using the 
coil-protected technique. Sixteen patients were treated with 
NBCA alone, three with Onyx alone, and three with both. 
Of the 36 feeding arteries, 28 (77.8%) were embolized with 
NBCA, and 8 (22.2%) were embolized with Onyx. Delivery of 
the liquid embolic agents into a target shunt of a dural AVF 
(dAVF) or a weak point of an AVM nidus was successful in 
Fig. 2. Findings for 69-year-old man presenting with nausea and vomiting that had aggravated over 3 months.
A. Right vertebral angiogram shows dural arteriovenous fistula with engorged perimedullary draining vein at craniocervical junction. B. Fusion 
image obtained with dual 3-dimensional volume reconstruction shows relationship of two feeders, one from right vertebral artery (white color) 
and other from occipital artery (red color). Note that two feeders are connected near right vertebral artery (arrow). C. Non-subtracted angiogram 
obtained just before embolization. Arrows indicate tips of two microcatheters in feeding branch of right occipital artery, proximal microcatheter 
for coiling and distal microcatheter for injection of NBCA. Note coils placed between two catheter tips. Arrowhead indicates proximal marker of 
balloon catheter for protection of NBCA reflux into right vertebral artery during embolization. Short arrow indicates coil mass occluding another 
branch of right occipital artery, which is occluded to facilitate navigation of microcatheter into target feeding artery. D. Spot image obtained 
after injection of 11.5% NBCA. Arrow indicates reflux of NBCA into feeder arising from right vertebral artery, which is protected by inflated 
balloon. Use of inflated balloon during injection of NBCA prevents NBCA from refluxing into vertebral artery through its feeder, which joins with 
feeder of right occipital artery. E. Right vertebral angiogram shows complete occlusion of fistula. NBCA = N-butyl cyanoacrylate
A
D
B
E
C
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all 36 feeders without any unintentional reflux. Immediately 
post-embolization, angiographies demonstrated complete 
occlusion in 16 patients (72.7%), near-complete occlusion 
in three patients (13.6%), and partial occlusion in three 
patients (13.6%). The three partial occlusions were all 
in patients with AVM. There were no treatment-related 
complications. Of the six patients with near-complete or 
partial occlusion, five received additional treatments. Two 
patients received stereotactic radiosurgery for cerebral 
AVM, two underwent surgical removal of cerebral AVM, 
Fig. 3. Findings for 30-year-old man presenting with exophthalmos and tinnitus.
A. MR angiogram shows multiple fistulas in left orbital and left temporal regions. B. Left external angiogram in working projection shows 
intraosseous fistula fed by multiple feeders in left temporal bone. C. Non-subtracted spot image obtained just after injection of 12% NBCA by 
proximal coil-protected technique. Note refluxes to other feeders (short arrows) from fistula, which mimics phenomenon during Onyx (Medtronic) 
embolization. Long arrow indicates coil mass and final coil is not detached. D. Left internal carotid angiogram in working projection. Enlarged 
left ophthalmic artery is main feeding artery into shunt, which forms multiple venous pouches (asterisks) and then drains through superior 
ophthalmic vein and pterygoid plexus. E. Spot image obtained just after proximal coil-protected NBCA embolization. Coil delivery catheter is 
located at lacrimal branch of left ophthalmic artery (arrow). Final coil is not yet detached. F. Left common carotid angiogram shows complete 
occlusion of left temporal bone fistula and near-complete occlusion of left orbit fistula. G. 12-month follow-up MR angiogram shows no 
recurrence of fistulas in left orbit and left temporal bone. MR = magnetic resonance
A
D
G
B
E
C
F
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and one underwent additional liquid embolization for a 
mandibular AVM by direct puncture through the mental 
foramen. One patient who had Maffuci’s syndrome and near-
complete occlusion did not receive additional treatment 
because the patient’s presenting symptoms (headache and 
exophthalmos) completely resolved and follow-up magnetic 
resonance angiography showed an improvement in vascular 
occlusion. Finally, all patients showed complete (n = 19) or 
near-complete occlusion (n = 3) of the target AVF or AVM 
nidus on follow-up angiographies. Clinically, presenting 
neurological symptoms improved completely in 15 patients 
(68.2%) and partially in seven patients (31.8%). 
DISCUSSION
Using the coil-protected technique, a sufficient amount 
of liquid embolic agent could be successfully delivered 
into the lesion of a dAVF or the weak point (suspected 
rupture point or intra-nidal aneurysm) of an AVM in all 
attempted cases. There was no treatment-related morbidity 
or mortality. Therefore, we believe that this technique can 
provide satisfactory immediate and follow-up angiographic 
and clinical outcomes. 
Endovascular embolization is a front-line treatment 
for neurovascular shunts or malformations. It can be 
conducted via transvenous, transarterial, or both routes. 
Transvenous embolization is the treatment of choice and 
is effective for cavernous sinus dAVFs (10). However, 
transvenous embolization may show limited effectiveness 
in treating AVFs at other locations and cannot be used for 
AVMs, necessitating transarterial embolization. There are 
potentially serious risks related to liquid embolization for 
the treatment of neurovascular shunt diseases. Insufficient 
penetration of the liquid embolic agent into the target shunt 
leads to incomplete embolization and results in the blockage 
of an access route to the target site (1, 2). Unintentional 
reflux may occlude functional arterial branches that supply 
Fig. 4. Findings for 8-year-old boy presenting with intracerebral hemorrhage from de novo arteriovenous malformation.
A. Frontal angiogram shows arteriovenous malformation with intranidal aneurysm (arrow), which is rupture point. B. Non-subtracted image of 
angiogram obtained just after embolization. Note segment of feeding artery where coil mass is placed (arrowheads). Straight and curved arrows 
indicate microcatheter for coiling and microcatheter for Onyx injection, respectively. C. 26-month follow-up delayed arterial phase angiogram 
shows complete occlusion of arteriovenous malformation. 
A B C
Table 2. Liquid Embolic Agents and Immediate and Follow-Up 
Outcomes
Liquid embolic agents, n (%)
N-butyl cyanoacrylic acid 16 (72.7)
Onyx* 3 (13.6)
Both 3 (13.6)
Immediate angiographic results, n (%)
Complete occlusion 16 (72.7)
Near-complete occlusion 3 (13.6)
Partial occlusion 3 (13.6)
Additional treatment, n (%)
Stereotaxic radiosurgery 2 (9.1)
Open surgery 2 (9.1)
Liquid embolization with direct puncture 1 (4.5)
Results of clinical follow-up
Follow-up period (months), median (range) 11 (2–48)
Complete recovery from presenting symptoms, 
  n (%)
15 (68.2)
Partial recovery, n (%) 7 (31.8)
Results of imaging follow-up, median (range), 
  months
Follow-up period (months), median (range) 9 (2–24)
Complete occlusion, n (%) 19 (86.4)
Near-complete occlusion, n (%) 3 (13.6)
*Onyx; Medtronic
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normal nervous tissues. Furthermore, premature occlusion 
of the main draining veins could potentially cause a 
disturbance in venous drainage. This problem is particularly 
prominent in AVMs with a high flow shunt and can result in 
serious complications such as hemorrhage or venous infarct 
(11, 12).
The microcatheter wedge technique has been used for 
controlled delivery of a sufficient amount of embolic agent 
to the target lesion while avoiding serious complications 
(5, 6). However, in a substantial proportion of cases, it is 
quite challenging to wedge a microcatheter because of the 
tortuosity of the feeding artery. Additionally, this carries a 
risk of arterial dissection or vasospasm, which would result 
in a loss of the access route. When Onyx is used as an 
embolic agent, the proximal Onyx plug formation technique 
with a detachable microcatheter, also known as the “plug 
and push technique,” is implemented. Although it can be 
effective in most cases, the “plug and push technique” 
is difficult to perform in cases with small and tortuous or 
highly resistant feeder vessels, such as in transosseous 
arteries. Another alternative technique using a dual-lumen 
balloon catheter for Onyx embolization has recently been 
reported (7). However, in small or very tortuous arteries, 
this method still causes difficulties in navigating the dual-
lumen balloon catheter to the target arterial point and 
carries the risk of arterial injuries such as dissection or 
rupture. Furthermore, this dual-lumen balloon catheter 
cannot be employed with NBCA embolization because the 
NBCA-lipiodol mixture causes the balloon to rupture shortly 
after contact.
In this study, we demonstrated that the coil-protected 
technique can be used for safe and effective embolization 
to treat various spinal and cranial neurovascular shunt 
diseases in which the feeding arteries may be too tortuous 
to wedge a microcatheter tip. A similar technique had 
previously been reported in two small cases series for 
NBCA embolization of spinal dAVFs (13, 14). Previous 
investigators termed the technique “two microcatheter 
or induced wedge technique.” In the present study, we 
extended the application of this technique to cranial dAVFs 
and cranial AVMs in addition to spinal dAVFs. Our results 
demonstrated that placement of the coils just proximal to 
the microcatheter tip used for embolization allows artificial 
wedging of the microcatheter for NBCA embolization. 
This approach also functioned as a firm plug for forward 
advancement of Onyx (Fig. 3). Consequently, the coil-
protection technique resulted in the delivery of a sufficient 
amount of the liquid embolic agent into the target shunt 
of dAVFs or the weak point of AVM niduses while avoiding 
unintentional reflux. In addition, proximal occlusion of the 
feeder vessel with coils blocked arterial inflow beyond the 
coils, which made it possible to control the delivery of the 
embolic agent. Subsequently, this technique was useful 
to prevent premature occlusion of the main draining vein. 
Although the coil-protected technique was technically 
successful in all our cases, immediate post-treatment 
angiography showed partial occlusion in three AVM cases. 
For embolization of the AVM, even when the liquid embolic 
agent reaches the target (such as an intranidal aneurysm) 
of the nidus, complete occlusion may not be achieved, 
especially when the AVM has multiple feeding arteries and 
draining veins. It is well known that the complete occlusion 
rate after embolization of AVMs is relatively low with the 
current technique and embolic agents in comparison to that 
after embolization of dAVF. However, the final treatment 
goal (occlusion of active bleeding point or pseudoaneurysm) 
can be achieved in AVMs even when the nidus is partially 
occluded.
When using the proximal coil-protected technique, a low 
(10–20%) concentration of NBCA seems to be better than 
a routine (25–33%) or high concentration of NBCA. The 
distance and amount of the mixture delivered depend on 
the interaction between the viscosity and polymerization 
time. Reflux is more likely to occur at higher viscosities, 
while a lower polymerization reaction time results in a 
longer injection time. As the NBCA concentration in the 
NBCA-lipiodol mixture decreases, the viscosity increases 
but the polymerization reaction becomes slower (15, 16). 
However, in the coil-protected technique, reflux of the 
NBCA-lipiodol mixture was almost completely blocked even 
with a low-concentration NBCA-lipiodol mixture. Therefore, 
the slower polymerization allowed a slower injection, which 
in turn made it possible to deliver a sufficient amount 
of the mixture to the target lesion with reduced distal 
migration into the draining vein (Fig. 2) (16-18).
This study has several limitations. First, it was a 
retrospective study with a relatively small number of cases. 
Given that the coil-protected technique is a problem-
solving technique rather than a front-line method for 
transarterial embolization, a prospective and comparative 
study was difficult to implement. Nevertheless, we believe 
that our results are unlikely to be affected by selection 
bias because all cases were registered in the prospectively 
maintained neurointerventional database with descriptions 
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of the procedural details and complications. Therefore, 
we cautiously suggest that our results may provide more 
options for embolization methods in the treatment of 
neurovascular shunt diseases. 
In conclusion, the coil-protected technique can be used 
as a safe and effective method for liquid embolization, 
especially in patients with various neurovascular shunt 
malformations who could not be successfully treated with 
conventional techniques.
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